Synthesis and Bioconversion of Curcumin Analogs

Area of Science:

• Natural Product Chemistry
• Microbial Biotechnology
• Medicinal Chemistry

Background:

• Curcumin, derived from Curcuma longa L., is recognized for its chemopreventive properties.
• Understanding the metabolic fate of curcumin is crucial for developing new therapeutic agents.

Purpose of the Study:

• To investigate the hydrogenation and microbial biotransformation of curcumin.
• To identify and characterize novel curcumin metabolites.
• To explore the biological activities of these derived compounds.

Main Methods:

• Chemical hydrogenation of curcumin.
• Biotransformation of curcumin and its hydrogenated derivatives using Beauveria bassiana and Rhizopus oryzae.
• Structural elucidation of metabolites using spectroscopic techniques.

Main Results:

• Hydrogenation yielded three major compounds: 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione (2), 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-one (3), and 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-diol (4).
• Beauveria bassiana transformed compound (2) into hexahydrocurcumin (3) and curcumin (1) into metabolites (2-6).
• Rhizopus oryzae yielded analogs (2-4) from curcumin (1); Aspergillus niger showed no transformation.

Conclusions:

• Microbial biotransformation offers a viable route to generate diverse curcumin analogs.
• The identified metabolites represent novel chemical entities with potential for further biological evaluation.
• This study expands the chemical diversity of curcumin derivatives for drug discovery.